FDA Submission Expected This Summer - Invest Before It Happens
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Shares Stats
| Shares Outstanding | 71,900,000 |
| Shares Float | 71,450,000 |
| Shares Short | 1,830,000 |
| Insider Holdings | 61% |
| Institution Holdings | 97.49% |
About West Pharmaceutical Services, Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
General
| Name | West Pharmaceutical Services, Inc |
| Ticker | WST |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 10,600 |
Highlights
| Analyst Target | 314.73 |
| Market Cap | 17,297,300,000 |
| PE Ratio | 36.03 |
| PEG Ratio | 3.47 |
| EBITDA | 789,500,032 |
Financials
| Curr Year EPS Estimate | 6.76 |
| Next Quarter EPS Estimate | 1.61 |
| Profit Margin | 16.48% |
| Operating Margin | 21.12 |
| Return on Assets | 0.11 |
| Return on Equity | 0.18 |
| Revenue | 3B |
| Earnings Per Share | 6.78 |
| Revenue Per Share | 40.83 |
| Gross Profit | 1,044,099,968 |
| Quarterly Revenue Growth | 0.09 |
Valuation
| Trailing PE | 35.48 |
| Forward PE | 37.59 |
| Price/Sales (Trailing 12 Mt.) | 5.84 |
| Price/Book (Most Recent Quarter) | 5.91 |
Dividend
West Pharmaceutical Services, Inc pays out a dividend of $0.54 per share, with a dividend yield of 0.22%.
WST's next dividend payment will be made to shareholders on November 19, 2025.
They pay out 12.27% of their earnings out as a dividend.
Recent Dividends
| Nov 19, 2025 | $0.22 |
| Aug 6, 2025 | $0.21 |
| May 7, 2025 | $0.21 |
| Feb 11, 2025 | $0.21 |
| Nov 20, 2024 | $0.21 |
| Aug 7, 2024 | $0.20 |
| May 1, 2024 | $0.20 |
| Feb 7, 2024 | $0.20 |
| Nov 15, 2023 | $0.20 |
Marjorie Taylor Greene Increases These 2 Stocks In Portfolio, Including This AI Name Up Over 100% YTD
Marjorie Taylor Greene has bought stocks multiple times in 2025 and her recent disclosure adds to one of the stocks that drew the biggest red flags in 2025.
These 3 Dividend-Yielding Stocks Could Outperform As High Fed Rates Spark $4.9 Billion Inflows: Expert
Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
New Jersey US Attorney Fired After Being Chosen Over Former Trump Lawyer Alina Habba
The U.S. Attorney for the District of New Jersey, Desiree Leigh Grace, has been dismissed by the Justice Department.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Denny's CEO Asks Potential Hires Only Two Questions But Reveals It 'Doesn't Matter What The Questions Are' — Here's Why
Denny's CEO Kelli Valade shares her hiring strategy of looking for red flags and self-awareness through thoughtful questions, not just answers.
At 14, Jamie Dimon Owned His First Stock, Watched A 45% Market Crash Only To Learn This Investment Lesson: 'History Does Rhyme'
Jamie Dimon, the CEO of JPMorgan Chase & Co., revealed the pivotal investment lesson he learned as a teenager.
The Surprising New Date That Could Fuel the AI Boom - Ad
Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.
Elon Musk Returns To Intense Work Schedule: 'Back To Working 7 Days a Week and Sleeping in the Office'
Elon Musk has announced his return to a grueling work schedule, indicating a shift back to "wartime CEO" mode.
Trump to visit Federal Reserve headquarters as feud with its chair continues
WASHINGTON (AP) — President Donald Trump is visiting the Federal Reserve headquarters in Washington Thursday, a week after indicating that Fed chair Jerome Powell's on two Fed buildings could be grounds for firing.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Trump-Backed DOJ Motion Seeks Release Of Jeffrey Epstein, Maxwell Grand Jury Transcripts
DOJ moves to unseal grand jury testimony related to Jeffrey Epstein and Ghislaine Maxwell following criticism over handling of documents.
Peter Thiel Effect? Cathie Wood Pours $175 Million Into Bitmine Immersion Stock As Founders Fund Backing, Ethereum Spike Fuels Buzz
Ark Invest, led by Cathie Wood, made significant trades on Monday.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Nvidia's CEO Hits Beijing Like A Rockstar, Stirs Jensen-Mania In China
Nvidia CEO Jensen Huang receives a rockstar reception in Beijing during his most recent visit last week.
TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook
TransMedics Group shares are rising in Wednesday's after-hours session after the company reported financial results for the second quarter.
Is Your Capital Following a Real Strategy? - Ad
Trade with $100K-$200K funded capital-no manual trading. Our AI system skips charts, eliminates stress, and lands you funding. Thousands passed prop challenges with us. Apply now, book a call, and have $10K ready.
FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers
Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.
What we know about a new health data tracking system being announced by White House
WASHINGTON (AP) — President Donald Trump's planned announcement Wednesday of a that would make it easier for patients to access their health records and monitor their wellness is raising a host of privacy concerns.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Martin Luther King Jr. FBI Records Released By Trump Administration: Al Sharpton Says, 'Desperate Attempt' To Distract People From Epstein Firestorm
Trump administration released over 240,000 pages of FBI surveillance records on Martin Luther King Jr., sparking controversy among his family and civil rights organizations.
Britain and Australia to sign 50-year nuclear submarine treaty
MELBOURNE, Australia (AP) — Britain and Australia announced they will sign a cooperation treaty to build Australian nuclear-powered submarines and welcomed a review by administration of the United States' role in the trilateral defense deal.
Trading Isn't Your Job. Let the System Handle It. - Ad
HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter?
Ethereum, XRP, SOL Surge After GENIUS Act: What's Driving The Altcoin Rally?
The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto legislation to date, ushering in structural clarity for digital assets.
Oklo Stock Hit A New 52-Week High Today: What's Driving The Action?
Shares of advanced nuclear technology company Oklo are trading higher Thursday. The company announced a strategic alliance with Liberty Energy on Wednesday.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Bitcoin Consolidation Means Market Is 'Relatively Healthy', Ethereum, XRP, SOL Will Continue To Do Well, Analyst Says
Bitcoin (CRYPTO: BTC) consolidates as Ethereum (CRYPTO: ETH) and Solana (CRYPTO: SOL) show strength, leading market commentators to predict th
NYU Professor Warns Companies Against Moving Cash Into Bitcoin — Unless You're Strategy, PayPal, Or A Meme Stock: 'This Is A Bad Idea'
NYU finance professor Aswath Damodaran is urging caution regarding corporate Bitcoin holdings, which have gained traction in recent years, with just four notable exceptions.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Europe's central bank to hold off on another rate cut until it knows how bad the tariff blow will be
FRANKFURT, Germany (AP) — The European Central Bank will likely hold off on making another interest rate cut Thursday, choosing to wait until it can measure the size of any economic blow from .
Business News Digest
AP Business Digest
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Millions Over Morals: Survey Reveals Americans' Willingness To Sacrifice Love And Loyalty For Cash
A recent poll has uncovered that a significant number of Americans would willingly forsake love, betray friends, and even risk their own lives for a million-dollar windfall.
A US judge says arrested Haitian businessman and former presidential hopeful will remain in custody
SAN JUAN, Puerto Rico (AP) — A federal immigration judge in Miami ordered on Thursday that wealthy remain in custody in the United States, where he is held over accusations of supporting .
Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad
Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.
Beef: It's What's for Dinner — If You Can Afford It
Here's a look at why beef is the latest item driving grocery bills higher.
Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal
TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .
The Surprising New Date That Could Fuel the AI Boom - Ad
Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.